glp-1 controversy The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.' cms/10.1056/NEJMra2500106/asset/6b655...

For a comprehensive guide to managing interruptions, the semaglutide protocol management article covers all disruption scenarios

In the body, spironolactone is metabolized, or broken down, into different substances that are responsible for the therapeutic and adverse effects of the medication

Lower total volume than a typical hypertrophy program: Because recovery capacity is often reduced on GLP-1s, I program fewer total sets per muscle group than I would for a client not on the medication, while keeping intensity high

Patients experiencing persistent vomiting, severe abdominal pain, or signs of pancreatitis should seek immediate medical attention

K.ThurmanJ